Additionally, knowledge gaps remain regarding the mechanisms whereby GEFs promote CRC, e.g., identifying binding partners necessary for GEF activation, and determining their precise role in governing neoplastic attributes including invasion, migration, and metastasis as well as resistance to apoptosis and anoikis. This evidence concerns the gene ARHGEF2 and colorectal carcinoma.